GLYCOBIOME

What this means for you

This application is over — abandoned 15 Dec 2015. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

86554584

Mark type

Stylized text

Filed

05 Mar 2015

Abandoned

15 Dec 2015

Attorney of record

Christina M. Licursi

Goods and services

• Class 042 — Scientific and technological services: Genetic testing for scientific research purposes; Genetic testing for medical purposes; scientific and technological services, including acquisition, collection, analysis, compilation, electronic storage and distribution of metagenomic, metaproteomic, metatranscriptomic, and metabolomic data and related clinical, agricultural, and veterinary data for treatment and diagnostic purposes of humans, animals, and plants; development of computer databases and computer-readable programs, software, and scientific, analytical, and statistical tools for genomic, proteomic, transcriptomic, and metabolomic data, including patient clinical care information, veterinary care information, agricultural data, and medical research data; chemical, biochemical, and molecular diagnostic services, including chemical, immunological, and microbiological diagnostic service bacteriological, virological, fungal, protistal, and molecular diagnostic services; acquisition, collection, analysis, compilation, storage and distribution of biological samples, including microbial and tissue samples; diagnostic services for assessing health and determining treatment for metabolism, diabetes, obesity, cardiovascular disease, malnutrition, short bowel syndrome, frailty, autism, allergy, atopy, neurological disorders, chronic or acute inflammatory diseases, inflammatory bowel disease, diverticulitis, non-alcoholic steatohepatitis, infection, susceptibility to infection, colonization with drug-resistant organisms, fertility, aging, cancer, and autoimmune diseases; scientific research in the field of genetics, genetic engineering of microbes, and molecular testing; Research and development in the pharmaceutical and biotechnology fields; microbial and anti-microbial preparations and substances for pharmaceutical, veterinary and medical purposes for use in the treatment of metabolic disorders, diabetes, obesity, cardiovascular disease, malnutrition, short bowel syndrome, frailty, autism, allergy, atopy, neurological disorders, chronic or acute inflammatory diseases, inflammatory bowel disease, diverticulitis, non-alcoholic steatohepatitis, infection, susceptibility to infection, colonization with drug-resistant organisms, fertility, aging, cancer, and autoimmune diseases; dietary supplements, nutritional supplements, nutraceuticals, food supplements, beverages, nutritional food bars, and animal feed or feed supplements containing microorganisms for medical, veterinary, therapeutic or preventative purposes; therapeutic pharmaceuticals containing microorganisms for medical and veterinary use for the treatment or prevention of metabolic disorders, diabetes, obesity, cardiovascular disease, malnutrition, short bowel syndrome, frailty, autism, allergy, atopy, neurological disorders, chronic or acute inflammatory diseases, inflammatory bowel disease, diverticulitis, non-alcoholic steatohepatitis, infection, susceptibility to infection, colonization with drug-resistant organisms, fertility, aging, cancer, and autoimmune diseases; therapeutics, consumer products and articles, including moisturizers, creams, lotions, gels, toners, cleansers, bandages, and cosmetics, pharmaceutical, veterinary and medical preparations and substances diagnostic kits and diagnostic reagents; diagnostics and tools for medical purposes; instruments, supplies and disposables; computer databases and computer-readable programs, software, and scientific, analytical, and statistical tools

Owner

• VL32, Inc., Cambridge, MA, US

Prosecution history

• 21 Jan 2016 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
• 21 Jan 2016 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
• 19 Jan 2016 — ASSIGNED TO EXAMINER
• 12 Jun 2015 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 12 Jun 2015 — NON-FINAL ACTION E-MAILED
• 12 Jun 2015 — NON-FINAL ACTION WRITTEN
• 10 Jun 2015 — ASSIGNED TO EXAMINER
• 18 Mar 2015 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED